| 产品名称: | Coxsackievirus A21 antiserum V-024-501-563 |
|---|---|
| 商品货号: | TS162465 |
| Deposited As: | Coxsackievirus A21 |
| Agent: | Coxsackievirus A21 antiserum V-024-501-563 |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried 0.5 mL |
| Storage Conditions: | 4°C |
| Comments: | Immunogen: Picornavirus, Enterovirus, Coxsackievirus A21, and Strain Kuykendall Source of antibody: Rhesus monkey Propagated in: human amnion cells in tissue culture Adjuvant: 1 part Arlacel A plus 9 parts Bayol F with equal amounts of undiluted suspension of virus |
| Name of Depositor: | NIH/NIAID, University of Kanasas Medical Center |
| Source: | Monkey immune serum prepared against Coxsackievirus A 21 strain Kuykendall |
| References: | Kamitsuka PS, et al. Preparation and standardization of Coxsackievirus reference antisera. I. For twenty-four group A viruses. Am. J. Epidemiol. 81: 283-306, 1965. PubMed: 14294414 Melnick JL, Ledinko N. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application. J. Exp. Med. 92: 463-482, 1950. PubMed: 14778925 |